Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.49 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.45 |
| ▸ | MEN1 | O00255 | 5/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | GAA | P10253 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | AURKA | O14965 | 1/20 | 0.35 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.35 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8163478 | 0.82 | GABRA1 (0.55) | GABRA1GABRB2KMT2AMEN1MAPT | |
| SCHEMBL5454241 | 0.81 | GABRA1 (0.43) | GABRA1GABRB2KMT2AMEN1MAPT | |
| SCHEMBL5227993 | 0.81 | GABRA1 (0.43) | GABRA1GABRB2KMT2AMEN1MAPT | |
| SCHEMBL4704501 | 0.79 | GABRA1 (0.52) | GABRA1GABRB2KMT2AMEN1MAPT | |
| SCHEMBL166586 | 0.79 | GABRA1 (0.52) | GABRA1GABRB2KMT2AMEN1MAPT | |
| SCHEMBL15677707 | 0.77 | KDM4E (0.47) | KMT2AMEN1MAPTGAAKDM4E | |
| SCHEMBL5074856 | 0.77 | KDM4E (0.47) | KMT2AMEN1MAPTGAAKDM4E | |
| SCHEMBL5074857 | 0.77 | KDM4E (0.47) | KMT2AMEN1MAPTGAAKDM4E | |
| SCHEMBL4453040 | 0.76 | GABRA1 (0.49) | GABRA1GABRB2KMT2AMEN1MAPT | |
| SCHEMBL6823137 | 0.76 | KMT2A (0.62) | GABRA1GABRB2KMT2AMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6673969-B2 | REACTING MIXTURE OF ALKYL-SALICYL-ALDEHYDES OR ALKYL-SALICYL-KETONES WITH HYDROXYLAMINE SULFATE OR HYDROXYLAMINE HYDROCHLORIDE; FOR EXTRACTING GALLIUM FROM WASTE EFFLUENTS FROM ORE PROCESSING, SUCH AS BAYER LIQUOR | COMSELHO NACIONAL DE DESENVOLVIMENTO CIENTIFICO E TECNOLOGICO CNPQ (BR) | 2004-01-06 | — | — | US | disclosed |
| US-20020123650-A1 | Process for preparation of oximes and resulting products | CETEM - CENTRO DE TECNOLOGIA MINERAL (BR) | 2002-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020123650-A1 | Process for preparation of oximes and resulting products | ACHE, LPO, GALE | GABRA1 4722/4885GABRB2 4811/4885KMT2A 726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.